Phase 1b trial of avelumab, an anti-PD-L1 antibody, in advanced gastric or gastroesophageal junction cancer | Dr Hendrik-Tobias Arkenau at ECC 2015

At the European Cancer Congress (ECC) 2015, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute UK, London, UK, discusses a phase 1b clinical trial that evaluated the safety and clinic... Author: EMJ Added: 10/02/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts